US Patent 7618979 Pyridopyrrolizine and pyridoindolizine derivatives
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+220 characters)
Article
Patent abstract
Pyridopyrrolizine and pyridoindolizine derivatives are prostaglandin receptor antagonists useful for the treatment of prostaglandin-mediated diseases such as allergic rhinitis, nasal congestion and asthma.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07618979 Pyridopyrrolizine and pyridoindolizine derivatives US Patent 7618979 Pyridopyrrolizine and pyridoindolizine derivatives
Infobox
Patent Number
0761897900
Patent Number
761897900
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076189790
Date of Patent
November 17, 2009
0Patent Application Number
105326330
Date Filed
October 28, 2003
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076189790
Date of Patent
November 17, 2009
0Patent Application Number
105326330
Date Filed
October 28, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07618979 Pyridopyrrolizine and pyridoindolizine derivatives
Infobox
Is a
Patent jurisdiction
Patent number
07618979
Date of patent
November 17, 2009
Patent application number
10532633
Date Filed
October 28, 2003
Patent primary examiner
Find more entities like US Patent 7618979 Pyridopyrrolizine and pyridoindolizine derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
